SCHEMBL1780256

SCHEMBL1780256

CCCc1[c]c(CCC)cc(C)c1

nearest known ligand 0.39

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 2/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
FFAR4 Q5NUL3 1/20 0.31
ALDH1A1 P00352 2/20 0.30
KDM4E B2RXH2 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5448243 0.89 NOS2 (0.37) NOS2NOS3NOS1
SCHEMBL27692561 0.88 NOS3 (0.35) NOS2NOS3NOS1
SCHEMBL1777232 0.85 NOS2 (0.42) NOS2NOS3NOS1ALDH1A1KDM4E
SCHEMBL1776980 0.81 PTGS2 (0.41) NOS2ALDH1A1KDM4EHTT
SCHEMBL6683472 0.81 PTGS2 (0.41) NOS2ALDH1A1KDM4EHTT
SCHEMBL9478817 0.80 NOS2 (0.39) NOS2ALDH1A1KDM4EHTT
SCHEMBL147801 0.79 CNR1 (0.37) FFAR4ALDH1A1HTT
SCHEMBL263267 0.78 NOS3 (0.34) NOS2NOS3ALDH1A1
SCHEMBL4250729 0.76
SCHEMBL2305735 0.73 MEN1 (0.31) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3476845-B1 ORGANIC THIN-FILM TRANSISTOR, ORGANIC SEMICONDUCTOR FILM, COMPOUND, ORGANIC-THIN-FILM-TRANSISTOR COMPOSITION, AND ORGANIC-THIN-FILM-TRANSISTOR MANUFACTURING METHOD FUJIFILM CORP (JP) 2021-07-21 EP claimed
CN-112771684-B Ink composition for manufacturing organic semiconductor device 株式会社大赛璐 2024-07-12 CN disclosed
US-20240025901-A1 METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND FUJIFILM CORPORATION (JP) 2024-01-25 US disclosed
US-11785845-B2 Composition FUJIFILM CORPORATION (JP) 2023-10-10 US disclosed
EP-3745484-B1 ORGANIC SEMICONDUCTOR ELEMENT, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM, METHOD FOR PRODUCING ORGANIC SEMICONDUCTOR FILM, AND POLYMER USED THEREFOR FUJIFILM CORP (JP) 2023-09-27 EP disclosed
US-11702557-B2 Ink composition for manufacturing organic semiconductor device DAICEL CORPORATION (JP) 2023-07-18 US disclosed
US-20230128569-A1 NOVEL COMPOUND AND APPLICATION THEREOF DAICEL CORPORATION (JP) 2023-04-27 US disclosed
CN-109478595-B Organic thin film transistor, organic semiconductor film, compound, composition for organic thin film transistor, and method for manufacturing organic thin film transistor 富士胶片株式会社 2023-02-07 CN disclosed
EP-4108657-A1 NEW COMPOUND AND USE THEREOF Daicel Corporation (JP) 2022-12-28 EP disclosed
US-20220389016-A1 COMPOUND AND METHOD FOR PRODUCING COMPOUND FUJIFILM CORPORATION (JP) 2022-12-08 US disclosed
US-20080221287-A1 DIENE POLYMER AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-09-11 US disclosed
US-20080221288-A1 DIENE POLYMER AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-09-11 US disclosed
US-20080221286-A1 DIENE POLYMER AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-09-11 US disclosed
US-20080214755-A1 OLEFIN-DIENE COPOLYMER AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-09-04 US disclosed
US-20080214754-A1 DIENE POLYMER AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-09-04 US disclosed
EP-0503785-B1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
US-5646171-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1997-07-08 US disclosed
US-5616599-A HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER SANKYO COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0545912-A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1993-06-09 EP disclosed
EP-0503785-A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1992-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220389016-A1 COMPOUND AND METHOD FOR PRODUCING COMPOUND DHPS, AZI2, CYP51A1 NOS2 590/4885NOS3 1937/4885NOS1 1184/4885
US-20240025901-A1 METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND INF2, NISCH, ITPA NOS2 88/4885NOS3 518/4885NOS1 270/4885
US-20230128569-A1 NOVEL COMPOUND AND APPLICATION THEREOF ABCG2, CXCR4, CCR10 NOS2 1103/4885NOS3 1096/4885NOS1 945/4885
US-11785845-B2 Composition ADH1A, ADH1C, SLC19A2 NOS2 536/4885NOS3 1104/4885NOS1 239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.